Great Diamond Partners, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Great Diamond Partners, LLC

  • $387 Million
  • Q3 2024

A detailed history of Great Diamond Partners, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Great Diamond Partners, LLC holds 335 shares of REGN stock, worth $235,367. This represents 0.09% of its overall portfolio holdings.

Number of Shares
335
Previous 589 43.12%
Holding current value
$235,367
Previous $619,000 43.13%
% of portfolio
0.09%
Previous 0.15%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
SELL
$1024.09 - $1201.76 $260,118 - $305,247
-254 Reduced 43.12%
335 $352,000
Q2 2024

Jul 29, 2024
SELL
$883.2 - $1071.19 $8,832 - $10,711
-10 Reduced 1.67%
589 $619,000
Q1 2024

May 08, 2024
SELL
$902.69 - $993.35 $7,221 - $7,946
-8 Reduced 1.32%
599 $576,000
Q4 2023

Feb 07, 2024
SELL
$775.18 - $881.7 $13,178 - $14,988
-17 Reduced 2.72%
607 $533,000
Q3 2023

Oct 19, 2023
BUY
$692.45 - $844.37 $692 - $844
1 Added 0.16%
624 $513,000
Q2 2023

Jul 17, 2023
BUY
$700.03 - $830.35 $18,200 - $21,589
26 Added 4.36%
623 $447,000
Q1 2023

May 04, 2023
BUY
$680.49 - $826.97 $2,721 - $3,307
4 Added 0.67%
597 $490,000
Q4 2022

Feb 01, 2023
SELL
$705.89 - $766.39 $91,059 - $98,864
-129 Reduced 17.87%
593 $427,000
Q3 2022

Oct 24, 2022
BUY
$573.97 - $724.32 $573 - $724
1 Added 0.14%
722 $497,000
Q2 2022

Jul 26, 2022
SELL
$548.35 - $738.84 $107,476 - $144,812
-196 Reduced 21.37%
721 $426,000
Q1 2022

May 05, 2022
SELL
$595.12 - $698.43 $31,541 - $37,016
-53 Reduced 5.46%
917 $640,000
Q4 2021

Jan 26, 2022
BUY
$543.48 - $670.97 $543 - $670
1 Added 0.1%
970 $612,000
Q3 2021

Oct 21, 2021
SELL
$574.03 - $680.96 $1,148 - $1,361
-2 Reduced 0.21%
969 $586,000
Q1 2021

May 04, 2021
SELL
$446.73 - $548.2 $20,549 - $25,217
-46 Reduced 4.52%
971 $459,000
Q4 2020

Jan 26, 2021
SELL
$478.3 - $607.98 $32,046 - $40,734
-67 Reduced 6.18%
1,017 $491,000
Q3 2020

Oct 19, 2020
BUY
$544.75 - $658.21 $3,268 - $3,949
6 Added 0.56%
1,084 $606,000
Q2 2020

Aug 04, 2020
SELL
$493.32 - $643.92 $26,639 - $34,771
-54 Reduced 4.77%
1,078 $672,000
Q1 2020

May 01, 2020
SELL
$336.18 - $494.43 $12,438 - $18,293
-37 Reduced 3.17%
1,132 $552,000
Q4 2019

Feb 07, 2020
BUY
$274.13 - $376.51 $320,457 - $440,140
1,169 New
1,169 $438,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Great Diamond Partners, LLC Portfolio

Follow Great Diamond Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Diamond Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Diamond Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email